Teva's CFO Eyal Desheh said at the Oppenheimer annual conference in Tel Aviv, that the healthcare reform will reduce Teva's revenue by $80-100M a year. http://www.globes.co.il/serveen/globes/docview.asp?did=1000560272&fid=942